Vasodilator and angioprotective activity of 1-ethyl-1-hydroxyalkyl-octahydroindolo[2,3a]quinolizine derivates.
- Z. Szombathelyi, E. Kárpáti, G. Kalaus, L. Szabó, C. Szántay
- Chemistry, Medicine
- 1 June 1991
The blood flow enhancing activity of the homologue series of "trans" racemic 1-ethyl-1-hydroxyalkyl-1,2,3,4,6,7,12,12b-octahydroindolo[2, 3a]quinolizine (1) was studied in anesthetized dogs. It was… Expand
2-halogennicergolinderivater or acid addition salts thereof, their preparation and use
Foerfarande Foer framstaellning of 2-halogenicergolinderivat Science deras syraadditionssalter Science nya 2-halogenicergoliner.
Foerfarande Foer framstaellning of (-) - 1-1 -hydroximetyl -etyl-1,2,3,4,6,7,12,12b-octahydroindolo / 2,3-a / -kinolizin.
[Experiences with isolated organ studies on pathological human arteries].
Pathological, muscular arteries (common and superficial femoral [FC, FS], anterior and posterior tibial [TA, TP] arteries) of patients suffering from arteriosclerosis obliterans (ASO),… Expand
Verwendung von (-)-1beta-Ethyl-1alpha-(hydroxymethyl)-1,2,3,4,6,7,12,12balpha-octahydroindolo[2,3-a]chinolisin zur Behandlung von mit Durchblutungsstörungen verbundenen Krankheiten
(-) - 1 (beta) ethyl-1 (alpha) - (hydroxymethyl) 1,2,3,4,6,7,12,12b (alpha) -octahydroindolo (2,3-a) and process chinolisin to its production
Comparative in vitro study of RGH-2981, a new peripheral blood flow enhancer on animal and pathological human arteries.
The aim of the present investigation was to compare the activity of RGH-2981 and two reference compounds, verapamil and LY 53857 on isolated, normal animal and pathological human arteries. The… Expand
Use of (-) - 1beta-ethyl-1alpha (hydroxymethyl) -1,2,3,4,6,7,12,12balpha-octahydroindolo [2,3-a] chinolisin for the treatment of diseases associated with circulatory disorders